Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

Share Price is delayed by 15 minutes
Get Live Data
222.00    -8.00 (-3.48%)
Bid:
215.00
Ask:
227.00
Spread: 12.00 (5.581%)
Market Cap: £117.21m
APTD Live PriceLast checked at - London Stock Exchange

Intraday Aptitude Share Chart

Trading Update and Board Changes

22 Oct 2015 07:00

RNS Number : 0335D
Microgen PLC
22 October 2015
 



microgen

www.microgen.com 22 October 2015

 

 

MICROGEN PLC

("MICROGEN" or "GROUP")

 

TRADING UPDATE AND BOARD CHANGES

 

 

Trading Update

 

The Group's Aptitude Software and Financial Systems businesses continue to perform in line with the Board's expectations. Consistent with this stage of the financial year, 95% of total expected revenue for 2015 is now contracted. High forward revenue visibility is a benefit of the Group's annual licensing model.

 

Appointments and Board Structure

 

Microgen is pleased to announce the appointment of Ivan Martin to the Board. Mr Martin will initially join the Board as a Non-Executive Director and Chairman Designate on 1 January 2016 before assuming the role of Non-Executive Chairman after the release of the 2015 Results.

 

Mr Martin (60) will chair the Nomination Committee and be a member of the Audit and Remuneration Committees. Mr Martin is currently Non-Executive Chairman of both FDM Group plc and Red Topco Limited (trading as Red), a specialist SAP-based IT services business. Previously Mr Martin was a member of Misys plc's board and headed their banking software division until 2005. Between 2007 and 2013, he was Executive Chairman of Sesame Bankhall Group and Non-Executive Director of Avelo.

 

The Managing Directors of the Group's two operating businesses have been attending Board Meetings by invitation since 2013 and will formally join the Board on 1 January 2016. Simon Baines (44) joined Microgen in 2010 as Managing Director of the Financial Systems business, prior to which he worked in private equity covering financial services technology companies. Tom Crawford (47) joined Microgen in 2003 and was appointed Head of Aptitude Software USA operations in 2010 before being promoted to Managing Director of Aptitude Software in 2013, a role that divides his time between Boston and London.

 

Martyn Ratcliffe, will step down as Chairman and as a Director after the release of the 2015 Results allowing a smooth transition to Mr Martin.

 

Regulatory Information - Ivan Martin

 

As at 21 October 2015 Mr Martin does not currently have any interest in any ordinary shares in Microgen. Mr Martin is Non-Executive Chairman of FDM Group plc.

 

There is no additional information required to be disclosed pursuant to Listing Rule 9.6.13R relating to the appointment to the Board of Mr Martin.

 

Regulatory Information - Simon Baines

 

As at 21 October 2015 Mr Baines is the beneficial owner of 9,523 ordinary shares in Microgen and has an interest in 650,000 unvested share options.

 

There is no additional information required to be disclosed pursuant to Listing Rule 9.6.13R relating to the appointment to the Board of Mr Baines.

 

Regulatory Information - Tom Crawford

 

As at 21 October 2015 Mr Crawford is the beneficial owner of 129,551 ordinary shares in Microgen and has an interest in 650,000 unvested share options.

 

There is no additional information required to be disclosed pursuant to Listing Rule 9.6.13R relating to the appointment to the Board of Mr Crawford.

 

 

Contacts

Martyn Ratcliffe, Chairman 020-7496-8100

Philip Wood, Group Finance Director

 

Rowena Murray, Investec 020-7597-5970

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFLRIVLLFIE
Date   Source Headline
8th Nov 20132:13 pmRNSHolding(s) in Company
6th Nov 20134:49 pmRNSHolding(s) in Company
6th Nov 20134:46 pmRNSHolding(s) in Company
1st Nov 20131:31 pmRNSPosting of Shareholder Circular
29th Oct 20137:02 amRNSStrategic Review
29th Oct 20137:00 amRNSInterim Management Statement
28th Oct 20134:32 pmRNSHolding(s) in Company
23rd Oct 20131:01 pmRNSHolding(s) in Company
1st Oct 201312:51 pmRNSDirector Declaration
26th Sep 20132:26 pmRNSBlocklisting Interim Review
25th Sep 20134:32 pmRNSHolding(s) in Company
9th Aug 20137:00 amRNSDirectorate Change
22nd Jul 20137:00 amRNSInterim Results
17th Jul 20132:36 pmRNSHolding(s) in Company
15th Jul 20132:19 pmRNSNotice of Interim Results
2nd Jul 20133:16 pmRNSBlocklisting Return
1st Jul 201310:14 amRNSTotal Voting Rights
27th Jun 20131:57 pmRNSHolding(s) in Company
3rd Jun 20139:50 amRNSTotal Voting Rights
13th May 201311:53 amRNSResults of AGM
13th May 20137:00 amRNSInterim Management Statement
1st May 20137:00 amRNSTotal Voting Rights
29th Apr 20135:23 pmRNSHolding(s) in Company
29th Apr 20135:16 pmRNSHolding(s) in Company
9th Apr 201312:11 pmRNSHolding(s) in Company
8th Apr 20135:20 pmRNSHolding(s) in Company
5th Apr 20134:35 pmRNSHolding(s) in Company
2nd Apr 201310:58 amRNSTotal Voting Rights
25th Mar 20134:06 pmRNSBlocklisting Interim Review
21st Mar 20134:53 pmRNSAnnual Information Update
21st Mar 20133:33 pmRNSDirectors Shareholdings
21st Mar 20133:28 pmRNSPDMR Shareholding
8th Mar 20132:37 pmRNSPosting of Annual Report and Notice of AGM
25th Feb 20137:00 amRNSPreliminary Results
19th Feb 20137:00 amRNSNotice of Results
4th Jan 201310:03 amRNSBlocklisting Interim Review
30th Nov 20129:24 amRNSTotal Voting Rights
12th Nov 20127:00 amRNSInterim Management Statement
31st Oct 20123:01 pmRNSTotal Voting Rights
23rd Oct 20122:12 pmRNSHolding(s) in Company
28th Sep 20122:15 pmRNSBlocklisting Interim Review
31st Aug 201210:00 amRNSTotal Voting Rights
31st Jul 20129:51 amRNSTotal Voting Rights
26th Jul 20127:00 amRNSTransaction in Own Shares
25th Jul 20127:00 amRNSTransaction in Own Shares
23rd Jul 20127:00 amRNSInterim Results
13th Jul 201210:32 amRNSNotice of Results
4th Jul 201211:12 amRNSBlocklisting Interim Review
2nd Jul 201211:29 amRNSTotal Voting Rights
30th Apr 20129:44 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.